Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-04-13 Sale | 2021-04-14 8:24 pm | SUPERNUS PHARMACEUTICALS Inc | SUPN | Martin Tami Tillotson VP | 6,250 | $30.98 | $193,639 | 101,951 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-18 Other | 2022-03-23 9:21 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | Khattar Jack A. CEO | 10,750 | $0 | 1,700,416 (Direct) | View |
| 2022-03-14 Option Award | 2022-03-17 5:10 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | Khattar Jack A. CEO | 60,000 | $0 | 1,678,916 (Direct) | View |
| 2022-02-22(A) Option Award | 2022-02-25 5:17 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Martin Tami Tillotson VP | 21,000 | $0 | 108,220 (Direct) | View |
| 2022-02-22(A) Option Award | 2022-02-25 5:17 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Bhatt Padmanabh P. VP | 21,000 | $0 | 21,894 (Direct) | View |
| 2022-02-22(A) Option Award | 2022-02-25 5:15 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Mottola Frank VP | 21,000 | $0 | 28,444 (Direct) | View |
| 2022-02-22(A) Option Award | 2022-02-25 5:15 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Rubin Jonathan SVP Chief Medical Officer | 28,000 | $0 | 28,000 (Direct) | View |
| 2022-02-22(A) Option Award | 2022-02-25 5:14 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | DEC TIMOTHY C CFO | 27,000 | $0 | 27,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:29 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Khattar Jack A. CEO | 250,000 | $0 | 1,868,916 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:27 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Bhatt Padmanabh P. VP | 21,000 | $0 | 21,894 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:26 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Mottola Frank VP | 21,000 | $0 | 28,444 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:26 pm | 2023-02-22 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | SIEBERT JOHN M Director | 10,729 | $0 | 90,904 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:25 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | DEC TIMOTHY C CFO | 27,000 | $0 | 27,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:24 pm | 2023-02-22 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Barlow Carrolee Director | 10,729 | $0 | 20,162 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:24 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Rubin Jonathan SVP Chief Medical Officer | 28,000 | $0 | 28,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:24 pm | 2023-02-22 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Hudson Frederick M. Director | 10,729 | $0 | 32,992 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:23 pm | 2023-02-22 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | NEWHALL CHARLES W III Director | 10,729 | $0 | 112,460 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:22 pm | 2023-02-22 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | GEMAYEL GEORGES Director | 10,729 | $0 | 20,162 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:22 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Martin Tami Tillotson VP | 21,000 | $0 | 108,220 (Direct) | View |
| 2022-02-19 Disposition | 2022-02-23 4:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | NEWHALL CHARLES W III Director | 4,222 | $0 | 101,731 (Direct) | View |
| 2022-02-19 Option Award | 2022-02-23 4:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | NEWHALL CHARLES W III Director | 4,222 | $0 | 101,731 (Direct) | View |
| 2022-02-19 Disposition | 2022-02-23 4:19 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | Barlow Carrolee Director | 4,222 | $0 | 9,433 (Direct) | View |
| 2022-02-19 Option Award | 2022-02-23 4:19 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | Barlow Carrolee Director | 4,222 | $0 | 9,433 (Direct) | View |
| 2022-02-19 Disposition | 2022-02-23 4:17 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | GEMAYEL GEORGES Director | 4,222 | $0 | 9,433 (Direct) | View |
| 2022-02-19 Option Award | 2022-02-23 4:17 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | GEMAYEL GEORGES Director | 4,222 | $0 | 9,433 (Direct) | View |
| 2022-02-19 Disposition | 2022-02-23 4:16 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | Hudson Frederick M. Director | 4,222 | $0 | 22,263 (Direct) | View |
| 2022-02-19 Option Award | 2022-02-23 4:16 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | Hudson Frederick M. Director | 4,222 | $0 | 22,263 (Direct) | View |
| 2022-02-19 Disposition | 2022-02-23 4:15 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | SIEBERT JOHN M Director | 4,222 | $0 | 80,175 (Direct) | View |
| 2022-02-19 Option Award | 2022-02-23 4:15 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | SIEBERT JOHN M Director | 4,222 | $0 | 80,175 (Direct) | View |
| 2021-08-23 Option Award | 2021-08-24 5:17 pm | N/A 2031-08-23 | SUPERNUS PHARMACEUTICALS Inc | SUPN | DEC TIMOTHY C CFO | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-08-11 Exercise | 2021-08-12 4:32 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | SIEBERT JOHN M Director | 15,000 | $12.98 | 75,953 (Direct) | View |
| 2021-08-11 Exercise | 2021-08-12 4:32 pm | 2017-03-01 2026-03-01 | SUPERNUS PHARMACEUTICALS Inc | SUPN | SIEBERT JOHN M Director | 15,000 | $0 | 75,953 (Direct) | View |
| 2021-07-30 Option Award | 2021-07-30 4:32 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | Khattar Jack A. CEO | 40,000 | $0 | 1,618,916 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-14 8:24 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | Martin Tami Tillotson VP | 6,250 | $12.98 | 101,951 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-14 8:24 pm | N/A 2026-03-01 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Martin Tami Tillotson VP | 6,250 | $0 | 101,951 (Direct) | View |
| 2021-03-26 Other | 2021-03-30 6:23 pm | N/A N/A | SUPERNUS PHARMACEUTICALS Inc | SUPN | Khattar Jack A. CEO | 10,000 | $0 | 1,598,916 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:55 pm | N/A 2031-02-19 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Kelly James Patrick CFO | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:54 pm | N/A 2031-02-19 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Rubin Jonathan SVP Chief Medical Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:54 pm | N/A 2031-02-19 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Martin Tami Tillotson VP | 17,000 | $0 | 103,326 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:53 pm | N/A 2031-02-19 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Mottola Frank VP | 17,000 | $0 | 23,839 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:51 pm | N/A 2031-02-19 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Bhatt Padmanabh P. VP | 17,000 | $0 | 17,000 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:49 pm | N/A 2031-02-19 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Khattar Jack A. CEO | 200,000 | $0 | 1,778,916 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:49 pm | 2022-02-19 2031-02-19 | SUPERNUS PHARMACEUTICALS Inc | SUPN | SIEBERT JOHN M Director | 11,587 | $0 | 72,540 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:48 pm | 2022-02-19 2031-02-19 | SUPERNUS PHARMACEUTICALS Inc | SUPN | GEMAYEL GEORGES Director | 11,587 | $0 | 16,798 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:47 pm | 2022-02-19 2031-02-19 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Hudson Frederick M. Director | 11,587 | $0 | 29,628 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:46 pm | 2022-02-19 2031-02-19 | SUPERNUS PHARMACEUTICALS Inc | SUPN | NEWHALL CHARLES W III Director | 11,587 | $0 | 109,096 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:46 pm | 2022-02-19 2031-02-19 | SUPERNUS PHARMACEUTICALS Inc | SUPN | Barlow Carrolee Director | 11,587 | $0 | 16,798 (Direct) | View |